Metronidazole Injection is a sterile, parenteral dosage form of metronidazole in water. Metronidazole is classified as a synthetic antibacterial and antiprotozoal agent and is administered by the intravenous route. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Metronidazole Injection and other antibacterial drugs, Metronidazole Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Metronidazole injection is used to treat certain skin, blood, bone, joint, gynecologic, and abdominal (stomach area) infections caused by bacteria. It is also used to treat endocarditis (infection of the heart lining and valves), meningitis (infection of the membranes that surround the brain and spinal cord), and certain respiratory infections, including pneumonia. Metronidazole injection is also to prevent infection when used before, during, and after colorectal surgery. Metronidazole injection is in a class of medications called antibacterials. It works by killing bacteria and protozoa that cause infection.
The global Metronidazole Injection market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2029, growing at a CAGR of % during 2021-2029.
This report focuses on Metronidazole Injection volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Metronidazole Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Metronidazole Injection Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Dosage Form & Strength Type
500mg/100mL
50mg/10mL
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma
1 Metronidazole Injection Market Overview
1.1 Product Overview and Scope of Metronidazole Injection
1.2 Metronidazole Injection Segment by Dosage Form & Strength Type
1.2.1 Global Metronidazole Injection Sales Growth Rate Comparison by Dosage Form & Strength Type (2021-2029)
1.2.2 500mg/100mL
1.2.3 50mg/10mL
1.3 Metronidazole Injection Segment by Application
1.3.1 Global Metronidazole Injection Sales Comparison by Application: (2021-2029)
1.3.2 Adult Use
1.3.3 Pediatric Use
1.3.4 Geriatric Use
1.4 Global Metronidazole Injection Market Size Estimates and Forecasts
1.4.1 Global Metronidazole Injection Revenue 2016-2029
1.4.2 Global Metronidazole Injection Sales 2016-2029
1.4.3 Metronidazole Injection Market Size by Region: 2016 Versus 2021 Versus 2029
2 Metronidazole Injection Market Competition by Manufacturers
2.1 Global Metronidazole Injection Sales Market Share by Manufacturers (2016-2021)
2.2 Global Metronidazole Injection Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Metronidazole Injection Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Metronidazole Injection Manufacturing Sites, Area Served, Product Type
2.5 Metronidazole Injection Market Competitive Situation and Trends
2.5.1 Metronidazole Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Metronidazole Injection Players Market Share by Revenue
2.5.3 Global Metronidazole Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Metronidazole Injection Retrospective Market Scenario by Region
3.1 Global Metronidazole Injection Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Metronidazole Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Metronidazole Injection Market Facts & Figures by Country
3.3.1 North America Metronidazole Injection Sales by Country
3.3.2 North America Metronidazole Injection Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Metronidazole Injection Market Facts & Figures by Country
3.4.1 Europe Metronidazole Injection Sales by Country
3.4.2 Europe Metronidazole Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Metronidazole Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Metronidazole Injection Sales by Region
3.5.2 Asia Pacific Metronidazole Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Metronidazole Injection Market Facts & Figures by Country
3.6.1 Latin America Metronidazole Injection Sales by Country
3.6.2 Latin America Metronidazole Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Metronidazole Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Metronidazole Injection Sales by Country
3.7.2 Middle East and Africa Metronidazole Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Metronidazole Injection Historic Market Analysis by Dosage Form & Strength Type
4.1 Global Metronidazole Injection Sales Market Share by Dosage Form & Strength Type (2016-2021)
4.2 Global Metronidazole Injection Revenue Market Share by Dosage Form & Strength Type (2016-2021)
4.3 Global Metronidazole Injection Price by Dosage Form & Strength Type (2016-2021)
5 Global Metronidazole Injection Historic Market Analysis by Application
5.1 Global Metronidazole Injection Sales Market Share by Application (2016-2021)
5.2 Global Metronidazole Injection Revenue Market Share by Application (2016-2021)
5.3 Global Metronidazole Injection Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Metronidazole Injection Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Metronidazole Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 B. Braun Medical Inc
6.2.1 B. Braun Medical Inc Corporation Information
6.2.2 B. Braun Medical Inc Description and Business Overview
6.2.3 B. Braun Medical Inc Metronidazole Injection Sales, Revenue and Gross Margin (2016-2021)
6.2.4 B. Braun Medical Inc Metronidazole Injection Product Portfolio
6.2.5 B. Braun Medical Inc Recent Developments/Updates
6.3 Sanofi-Aventis Canada Inc
6.3.1 Sanofi-Aventis Canada Inc Corporation Information
6.3.2 Sanofi-Aventis Canada Inc Description and Business Overview
6.3.3 Sanofi-Aventis Canada Inc Metronidazole Injection Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi-Aventis Canada Inc Metronidazole Injection Product Portfolio
6.3.5 Sanofi-Aventis Canada Inc Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Corporation Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Metronidazole Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Baxter Metronidazole Injection Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 JB Chemicals and Pharmaceuticals
6.5.1 JB Chemicals and Pharmaceuticals Corporation Information
6.5.2 JB Chemicals and Pharmaceuticals Description and Business Overview
6.5.3 JB Chemicals and Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2016-2021)
6.5.4 JB Chemicals and Pharmaceuticals Metronidazole Injection Product Portfolio
6.5.5 JB Chemicals and Pharmaceuticals Recent Developments/Updates
6.6 Qatar Pharma
6.6.1 Qatar Pharma Corporation Information
6.6.2 Qatar Pharma Description and Business Overview
6.6.3 Qatar Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Qatar Pharma Metronidazole Injection Product Portfolio
6.6.5 Qatar Pharma Recent Developments/Updates
6.7 Unique Pharmaceuticals
6.6.1 Unique Pharmaceuticals Corporation Information
6.6.2 Unique Pharmaceuticals Description and Business Overview
6.6.3 Unique Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Unique Pharmaceuticals Metronidazole Injection Product Portfolio
6.7.5 Unique Pharmaceuticals Recent Developments/Updates
6.8 Sagent Pharmaceuticals
6.8.1 Sagent Pharmaceuticals Corporation Information
6.8.2 Sagent Pharmaceuticals Description and Business Overview
6.8.3 Sagent Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sagent Pharmaceuticals Metronidazole Injection Product Portfolio
6.8.5 Sagent Pharmaceuticals Recent Developments/Updates
6.9 AdvaCare Pharma
6.9.1 AdvaCare Pharma Corporation Information
6.9.2 AdvaCare Pharma Description and Business Overview
6.9.3 AdvaCare Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2016-2021)
6.9.4 AdvaCare Pharma Metronidazole Injection Product Portfolio
6.9.5 AdvaCare Pharma Recent Developments/Updates
7 Metronidazole Injection Manufacturing Cost Analysis
7.1 Metronidazole Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Metronidazole Injection
7.4 Metronidazole Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Metronidazole Injection Distributors List
8.3 Metronidazole Injection Customers
9 Metronidazole Injection Market Dynamics
9.1 Metronidazole Injection Industry Trends
9.2 Metronidazole Injection Growth Drivers
9.3 Metronidazole Injection Market Challenges
9.4 Metronidazole Injection Market Restraints
10 Global Market Forecast
10.1 Metronidazole Injection Market Estimates and Projections by Dosage Form & Strength Type
10.1.1 Global Forecasted Sales of Metronidazole Injection by Dosage Form & Strength Type (2022-2029)
10.1.2 Global Forecasted Revenue of Metronidazole Injection by Dosage Form & Strength Type (2022-2029)
10.2 Metronidazole Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Metronidazole Injection by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Metronidazole Injection by Application (2022-2029)
10.3 Metronidazole Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Metronidazole Injection by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Metronidazole Injection by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Metronidazole Injection Sales (KL) Growth Rate Comparison by Dosage Form & Strength Type (2021-2029)
Table 2. Global Metronidazole Injection Sales (KL) Comparison by Application (2021-2029)
Table 3. Global Metronidazole Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Metronidazole Injection Covered in This Study
Table 5. Global Metronidazole Injection Sales (KL) of Key Manufacturers (2016-2021)
Table 6. Global Metronidazole Injection Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Metronidazole Injection Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Metronidazole Injection Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Metronidazole Injection Average Price (US$/L) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Metronidazole Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Metronidazole Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Metronidazole Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metronidazole Injection as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Metronidazole Injection Sales by Region (2016-2021) & (KL)
Table 16. Global Metronidazole Injection Sales Market Share by Region (2016-2021)
Table 17. Global Metronidazole Injection Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Metronidazole Injection Sales by Country (2016-2021) & (KL)
Table 19. North America Metronidazole Injection Sales Market Share by Country (2016-2021)
Table 20. North America Metronidazole Injection Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Metronidazole Injection Revenue Market Share by Country (2016-2021)
Table 22. Europe Metronidazole Injection Sales by Country (2016-2021) & (KL)
Table 23. Europe Metronidazole Injection Sales Market Share by Country (2016-2021)
Table 24. Europe Metronidazole Injection Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Metronidazole Injection Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Metronidazole Injection Sales by Region (2016-2021) & (KL)
Table 27. Asia Pacific Metronidazole Injection Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Metronidazole Injection Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Metronidazole Injection Revenue Market Share by Region (2016-2021)
Table 30. Latin America Metronidazole Injection Sales by Country (2016-2021) & (KL)
Table 31. Latin America Metronidazole Injection Sales Market Share by Country (2016-2021)
Table 32. Latin America Metronidazole Injection Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Metronidazole Injection Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Metronidazole Injection Sales by Country (2016-2021) & (KL)
Table 35. Middle East and Africa Metronidazole Injection Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Metronidazole Injection Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Metronidazole Injection Revenue Market Share by Country (2016-2021)
Table 38. Global Metronidazole Injection Sales (KL) by Dosage Form & Strength Type (2016-2021)
Table 39. Global Metronidazole Injection Sales Market Share by Dosage Form & Strength Type (2016-2021)
Table 40. Global Metronidazole Injection Revenue (Million US$) by Dosage Form & Strength Type (2016-2021)
Table 41. Global Metronidazole Injection Revenue Share by Dosage Form & Strength Type (2016-2021)
Table 42. Global Metronidazole Injection Price (US$/L) by Dosage Form & Strength Type (2016-2021)
Table 43. Global Metronidazole Injection Sales (KL) by Application (2016-2021)
Table 44. Global Metronidazole Injection Sales Market Share by Application (2016-2021)
Table 45. Global Metronidazole Injection Revenue (Million US$) by Application (2016-2021)
Table 46. Global Metronidazole Injection Revenue Share by Application (2016-2021)
Table 47. Global Metronidazole Injection Price (US$/L) by Application (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Metronidazole Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 51. Pfizer Metronidazole Injection Product
Table 52. Pfizer Recent Developments/Updates
Table 53. B. Braun Medical Inc Corporation Information
Table 54. B. Braun Medical Inc Description and Business Overview
Table 55. B. Braun Medical Inc Metronidazole Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 56. B. Braun Medical Inc Metronidazole Injection Product
Table 57. B. Braun Medical Inc Recent Developments/Updates
Table 58. Sanofi-Aventis Canada Inc Corporation Information
Table 59. Sanofi-Aventis Canada Inc Description and Business Overview
Table 60. Sanofi-Aventis Canada Inc Metronidazole Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 61. Sanofi-Aventis Canada Inc Metronidazole Injection Product
Table 62. Sanofi-Aventis Canada Inc Recent Developments/Updates
Table 63. Baxter Corporation Information
Table 64. Baxter Description and Business Overview
Table 65. Baxter Metronidazole Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 66. Baxter Metronidazole Injection Product
Table 67. Baxter Recent Developments/Updates
Table 68. JB Chemicals and Pharmaceuticals Corporation Information
Table 69. JB Chemicals and Pharmaceuticals Description and Business Overview
Table 70. JB Chemicals and Pharmaceuticals Metronidazole Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 71. JB Chemicals and Pharmaceuticals Metronidazole Injection Product
Table 72. JB Chemicals and Pharmaceuticals Recent Developments/Updates
Table 73. Qatar Pharma Corporation Information
Table 74. Qatar Pharma Description and Business Overview
Table 75. Qatar Pharma Metronidazole Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 76. Qatar Pharma Metronidazole Injection Product
Table 77. Qatar Pharma Recent Developments/Updates
Table 78. Unique Pharmaceuticals Corporation Information
Table 79. Unique Pharmaceuticals Description and Business Overview
Table 80. Unique Pharmaceuticals Metronidazole Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 81. Unique Pharmaceuticals Metronidazole Injection Product
Table 82. Unique Pharmaceuticals Recent Developments/Updates
Table 83. Sagent Pharmaceuticals Corporation Information
Table 84. Sagent Pharmaceuticals Description and Business Overview
Table 85. Sagent Pharmaceuticals Metronidazole Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 86. Sagent Pharmaceuticals Metronidazole Injection Product
Table 87. Sagent Pharmaceuticals Recent Developments/Updates
Table 88. AdvaCare Pharma Corporation Information
Table 89. AdvaCare Pharma Description and Business Overview
Table 90. AdvaCare Pharma Metronidazole Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 91. AdvaCare Pharma Metronidazole Injection Product
Table 92. AdvaCare Pharma Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Metronidazole Injection Distributors List
Table 96. Metronidazole Injection Customers List
Table 97. Metronidazole Injection Market Trends
Table 98. Metronidazole Injection Growth Drivers
Table 99. Metronidazole Injection Market Challenges
Table 100. Metronidazole Injection Market Restraints
Table 101. Global Metronidazole Injection Sales Forecast by Dosage Form & Strength Type (2022-2029) & (KL)
Table 102. Global Metronidazole Injection Sales Market Share Forecast by Dosage Form & Strength Type (2022-2029)
Table 103. Global Metronidazole Injection Revenue Forecast by Dosage Form & Strength Type (2022-2029) & (US$ Million)
Table 104. Global Metronidazole Injection Revenue Market Share Forecast by Dosage Form & Strength Type (2022-2029)
Table 105. Global Metronidazole Injection Sales Forecast by Application (2022-2029) & (KL)
Table 106. Global Metronidazole Injection Sales Market Share Forecast by Application (2022-2029)
Table 107. Global Metronidazole Injection Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 108. Global Metronidazole Injection Revenue Market Share Forecast by Application (2022-2029)
Table 109. Global Metronidazole Injection Sales Forecast by Region (2022-2029) & (KL)
Table 110. Global Metronidazole Injection Sales Market Share Forecast by Region (2022-2029)
Table 111. Global Metronidazole Injection Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 112. Global Metronidazole Injection Revenue Market Share Forecast by Region (2022-2029)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Metronidazole Injection
Figure 2. Global Metronidazole Injection Market Share by Dosage Form & Strength Type in 2020 & 2029
Figure 3. 500mg/100mL Product Picture
Figure 4. 50mg/10mL Product Picture
Figure 5. Global Metronidazole Injection Market Share by Application in 2020 & 2029
Figure 6. Adult Use
Figure 7. Pediatric Use
Figure 8. Geriatric Use
Figure 9. Global Metronidazole Injection Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 10. Global Metronidazole Injection Market Size 2016-2029 (US$ Million)
Figure 11. Global Metronidazole Injection Sales 2016-2029 (KL)
Figure 12. Global Metronidazole Injection Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 13. Metronidazole Injection Sales Share by Manufacturers in 2020
Figure 14. Global Metronidazole Injection Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Metronidazole Injection Players: Market Share by Revenue in 2020
Figure 16. Metronidazole Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Metronidazole Injection Sales Market Share by Region (2016-2021)
Figure 18. Global Metronidazole Injection Sales Market Share by Region in 2020
Figure 19. Global Metronidazole Injection Revenue Market Share by Region (2016-2021)
Figure 20. Global Metronidazole Injection Revenue Market Share by Region in 2020
Figure 21. United States Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Colombia Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Metronidazole Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Metronidazole Injection by Dosage Form & Strength Type (2016-2021)
Figure 45. Sales Market Share of Metronidazole Injection by Application (2016-2021)
Figure 46. Sales Market Share of Metronidazole Injection by Application in 2020
Figure 47. Revenue Share of Metronidazole Injection by Application (2016-2021)
Figure 48. Revenue Share of Metronidazole Injection by Application in 2020
Figure 49. Manufacturing Cost Structure of Metronidazole Injection
Figure 50. Manufacturing Process Analysis of Metronidazole Injection
Figure 51. Metronidazole Injection Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
